{"id":"https://openalex.org/W1997192647","doi":"https://doi.org/10.1212/wnl.47.6.1531","title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","display_name":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","publication_year":1996,"publication_date":"1996-12-01","ids":{"openalex":"https://openalex.org/W1997192647","doi":"https://doi.org/10.1212/wnl.47.6.1531","mag":"1997192647","pmid":"https://pubmed.ncbi.nlm.nih.gov/8960740"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.47.6.1531","doi":"https://doi.org/10.1212/wnl.47.6.1531","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.47.6.1531","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055329132","display_name":"Bob W. van Oosten","orcid":"https://orcid.org/0000-0003-4536-6201","observed_orcids":["https://orcid.org/0000-0003-4536-6201"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. W. van Oosten","raw_affiliation_strings":["Department of Neurology, Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064378373","display_name":"Frederik Barkhof","orcid":"https://orcid.org/0000-0003-3543-3706","observed_orcids":["https://orcid.org/0000-0003-3543-3706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Barkhof","raw_affiliation_strings":["Radiology and nuclear medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiology and nuclear medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113032293","display_name":"Laila Truyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L. Truyen","raw_affiliation_strings":["VU medisch centrum;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU medisch centrum;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039106389","display_name":"Jan Boringa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. B. Boringa","raw_affiliation_strings":["VU medisch centrum;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU medisch centrum;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027847006","display_name":"Frits W. Bertelsmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"F. W. Bertelsmann","raw_affiliation_strings":["VU medisch centrum;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU medisch centrum;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110064664","display_name":"Brigitta Mary E. Von Blomberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B.M.E. von Blomberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111511147","display_name":"James N. Woody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. N. Woody","raw_affiliation_strings":["Centocor, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063615479","display_name":"Hans\u2010Peter Hartung","orcid":"https://orcid.org/0000-0002-0614-6989","observed_orcids":["https://orcid.org/0000-0002-0614-6989"]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H.-P. Hartung","raw_affiliation_strings":["University of W\u00fcrzburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of W\u00fcrzburg","institution_ids":["https://openalex.org/I25974101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109933973","display_name":"Chris H. Polman","orcid":"https://orcid.org/0000-0002-9253-1743","observed_orcids":["https://orcid.org/0000-0002-9253-1743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. H. Polman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.6388,"has_fulltext":false,"cited_by_count":741,"citation_normalized_percentile":{"value":0.9832173,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"47","issue":"6","first_page":"1531","last_page":"1534"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/anti-tumor-necrosis-factor-therapy","display_name":"anti-tumor necrosis factor therapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.675000011920929},{"id":"https://openalex.org/keywords/mri-disease-activity","display_name":"MRI activity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7329999804496765},{"id":"https://openalex.org/keywords/mathematical-model","display_name":"mathematical model","score":0.4909999966621399},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.8539999723434448},{"id":"https://openalex.org/keywords/time-dependent-inactivation","display_name":"time-dependent inactivation","score":0.796999990940094},{"id":"https://openalex.org/keywords/cyp3a-induction","display_name":"CYP3A induction","score":0.9279999732971191},{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":0.6679999828338623},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9300000071525574},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.8809999823570251},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7596480846405029},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7225145697593689},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6407548189163208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5962981581687927},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5842586755752563},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.5391251444816589},{"id":"https://openalex.org/C118776929","wikidata":"https://www.wikidata.org/wiki/Q424381","display_name":"Tumor necrosis factors","level":3,"score":0.5152135491371155},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.5003738403320312},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4894351065158844},{"id":"https://openalex.org/C3020084786","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor \u03b1","level":3,"score":0.4679471552371979},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42772677540779114},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39941489696502686},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3213023543357849}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1212/wnl.47.6.1531","doi":"https://doi.org/10.1212/wnl.47.6.1531","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.47.6.1531","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:8960740","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8960740","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Case Reports"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1490139","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1490139/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NEUROLOGY , 47 (6) pp. 1531-1534. (1996)","raw_type":"Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/c5417790-57cc-475c-af76-768072759fb4","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/c5417790-57cc-475c-af76-768072759fb4","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Van Oosten, B W, Barkhof, F, Truyen, L, Boringa, J B, Bertelsmann, F W, Von Blomberg, B M E, Woody, J N, Hartung, H P & Polman, C H 1996, 'Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2', Neurology, vol. 47, no. 6, pp. 1531-1534. https://doi.org/10.1212/WNL.47.6.1531","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b5f14fdb-a27f-427c-ade3-a89c1cb3f35a","doi":null,"is_oa":false,"landing_page_url":"https://www.scopus.com/pages/publications/0029751983","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Van Oosten, B W, Barkhof, F, Truyen, L, Boringa, J B, Bertelsmann, F W, Von Blomberg, B M E, Woody, J N, Hartung, H P & Polman, C H 1996, 'Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2', Neurology, vol. 47, no. 6, pp. 1531-1534. https://doi.org/10.1212/WNL.47.6.1531","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/b5f14fdb-a27f-427c-ade3-a89c1cb3f35a","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/b5f14fdb-a27f-427c-ade3-a89c1cb3f35a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurology, 47(6), 1531 - 1534. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1589935359","https://openalex.org/W1960667696","https://openalex.org/W1964352003","https://openalex.org/W1969792162","https://openalex.org/W1989832126","https://openalex.org/W1991069898","https://openalex.org/W1991884672","https://openalex.org/W2000665475","https://openalex.org/W2024114227","https://openalex.org/W2035799122","https://openalex.org/W2045147557","https://openalex.org/W2047157165","https://openalex.org/W2056958245","https://openalex.org/W2079334007","https://openalex.org/W2080324970","https://openalex.org/W2085730152","https://openalex.org/W2113861816","https://openalex.org/W2416276975","https://openalex.org/W4235326125","https://openalex.org/W4236566581","https://openalex.org/W4237792806"],"related_works":["https://openalex.org/W2144815258","https://openalex.org/W2142667992","https://openalex.org/W2795767087","https://openalex.org/W1539466518","https://openalex.org/W3175406012","https://openalex.org/W2157851012","https://openalex.org/W3198546665","https://openalex.org/W7096902203","https://openalex.org/W4392167902","https://openalex.org/W2167342795"],"abstract_inverted_index":{"Although":[0],"approaches":[1,18,30],"to":[2,64,107,162,178,224],"the":[3,69,89,103,119,143,156,202,206],"prediction":[4,113],"of":[5,36,47,71,92,99,116,166],"drug-drug":[6,111],"interactions":[7],"(DDIs)":[8],"arising":[9,38,172,184],"via":[10,173,185],"time-dependent":[11,95,138],"inactivation":[12,139,174],"have":[13,79],"recently":[14],"been":[15],"developed,":[16],"such":[17],"do":[19,31],"not":[20,32],"account":[21],"for":[22,88,135,142,151,155],"simple":[23,40],"competitive":[24,41,93,136,186],"inhibition":[25,42,187],"or":[26,45],"induction.":[27],"Accordingly,":[28],"these":[29],"provide":[33,108,163],"accurate":[34],"predictions":[35,67,165],"DDIs":[37,171],"from":[39],"(e.g.,":[43,50,74,175,188,191,196],"ketoconazole)":[44],"induction":[46,98,141,190],"cytochromes":[48],"P450":[49],"phenytoin).":[51],"In":[52],"addition,":[53],"methods":[54],"that":[55,86],"focus":[56],"upon":[57],"a":[58,81,109,126,221],"single":[59],"interaction":[60,112],"mechanism":[61],"are":[62,198],"likely":[63],"yield":[65],"misleading":[66],"in":[68,101,114,132,205],"face":[70],"mixed":[72,194],"mechanisms":[73,195],"ritonavir).":[75],"As":[76],"such,":[77],"we":[78],"developed":[80],"more":[82],"comprehensive":[83,209],"mathematical":[84],"model":[85,124,210],"accounts":[87],"simultaneous":[90],"influences":[91],"inhibition,":[94,137],"inactivation,":[96],"and":[97,105,140,153,193,218,228],"CYP3A":[100],"both":[102],"liver":[104],"intestine":[106],"net":[110],"terms":[115],"area":[117],"under":[118],"concentration-time":[120],"curve":[121],"ratio.":[122],"This":[123,208],"provides":[125],"framework":[127],"by":[128],"which":[129],"readily":[130],"obtained":[131],"vitro":[133],"values":[134,150],"precipitant":[144],"compound":[145],"as":[146,148],"well":[147,180],"literature":[149],"fm":[152],"FG":[154],"object":[157],"drug":[158],"can":[159,219],"be":[160,179,220],"used":[161],"quantitative":[164],"DDIs.":[167,231],"Using":[168],"this":[169],"model,":[170],"erythromycin)":[176],"continue":[177],"predicted,":[181],"whereas":[182],"those":[183],"ketoconazole),":[189],"phenytoin),":[192],"ritonavir)":[197],"also":[199],"predicted":[200],"within":[201],"ranges":[203],"reported":[204],"clinic.":[207],"quantitatively":[211],"predicts":[212],"clinical":[213,230],"observations":[214],"with":[215],"reasonable":[216],"accuracy":[217],"valuable":[222],"tool":[223],"evaluate":[225],"candidate":[226],"drugs":[227],"rationalize":[229]},"counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":25},{"year":2020,"cited_by_count":28},{"year":2019,"cited_by_count":21},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":35},{"year":2013,"cited_by_count":27},{"year":2012,"cited_by_count":33}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}